Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haptoglobin polymorphism and chronic hepatitis C

H K Louagie1, J T Brouwer, J R Delanghe

  • 1Department of Clinical Chemistry, Microbiology and Immunology, University Hospital Gent, Belgium.

Journal of Hepatology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D and Vitamin D binding protein: the inseparable duo in COVID-19.

Journal of endocrinological investigation·2021
Same author

The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Variability of serum concentrations of cystatin C and urinary retinol-binding protein, neutrophil gelatinase-associated lipocalin, immunoglobulin G, and C-reactive protein in dogs.

Journal of veterinary internal medicine·2018
Same author

Secukinumab: IL-17A inhibition to treat psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2017
Same author

Reproducibility and least significant differences of oral glucose tolerance test-derived parameters in a postmenopausal population without diabetes.

Diabetes & metabolism·2017
Same author

The intriguing role of soluble urokinase receptor in inflammatory diseases.

Critical reviews in clinical laboratory sciences·2017
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
Same journal

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
See all related articles

Hepatoglobin (Hp) phenotype distribution differs in chronic hepatitis C patients compared to healthy individuals. This shift suggests a potential role for Hp in the natural progression of hepatitis C virus infection.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Virology

Background:

  • Haptoglobin (Hp) is a genetic acute phase protein with known immune functions.
  • Previous studies indicated lower serum Hp concentrations in hepatitis C patients.
  • Hp exhibits genetic polymorphism with three phenotypes: Hp 1-1, Hp 2-1, and Hp 2-2.

Purpose of the Study:

  • To investigate differences in Hp phenotype distribution between chronic hepatitis C patients and a healthy reference population.
  • To explore potential associations between Hp phenotypes and hepatitis C virus types.
  • To examine relationships between Hp phenotypes and response to interferon alpha therapy.

Main Methods:

  • Study included 239 Caucasian patients with chronic hepatitis C and 220 healthy controls.

Related Experiment Videos

  • Hp phenotypes were determined using starch gel electrophoresis.
  • Serum Hp concentrations were measured via immunonephelometry; HCV genotyping was performed.

    • Main Results:

    • Hp phenotype distribution and allele frequencies significantly differed between chronic hepatitis C patients and the reference group.
    • The Hp 1 allele frequency was higher in patients (0.481) than in controls (0.400).
    • No significant associations were found between Hp phenotypes and HCV types or interferon therapy response.

    Conclusions:

    • The altered Hp phenotype distribution in chronic hepatitis C patients suggests a role for haptoglobin in the disease's natural course.
    • Further research is warranted to elucidate the specific mechanisms involved.